Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

Efficacy of chloroquine versus lopinavir/ritonavir in mild/general COVID-19 infection: a prospective, open-label, multicenter, randomized controlled clinical study

Abstract Background The outbreak of COVID-19 (caused by SARS-Cov-2) is very serious, and no effective antiviral treatment has yet been confirmed. The adage “old drug, new trick” in this context may suggest the important therapeutic potential of existing drugs. We found that the lopinavir/ritonavir t...

Full description

Bibliographic Details
Main Authors: Xi Liu, Huili Chen, Yuqi Shang, Hongqiong Zhu, Gongqi Chen, Yuanli Chen, Shaoxuan Liu, Yaoyong Zhou, Mingxing Huang, Zhongsi Hong, Jinyu Xia
Format: Article
Language:English
Published: BMC 2020-07-01
Series:Trials
Subjects:
COVID-19
Chloroquine
Lopinavir/ritonavir
Randomized controlled clinical study
Efficacy
Online Access:http://link.springer.com/article/10.1186/s13063-020-04478-w

Internet

http://link.springer.com/article/10.1186/s13063-020-04478-w

Similar Items